TREAT Asia Studies to Evaluate Resistance - Monitoring (TASER-M)
TASER-M is a longitudinal cohort aimed at monitoring drug resistance in treatment naïve individuals initiating treatment for human immunodeficiency virus (HIV), as well as those who failed first time treatment. The participants include individuals over 18 years old who have a confirmed HIV-1 infection. The study takes place across multiple countries including Thailand, Hong Kong, and Malaysia. Participants are followed annually, during which time, treatment outcomes are monitored.
Study design
Cohort - clinical
Number of participants at first data collection
773 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2008
Primary Institutions
University of New South Wales (UNSW) (Academic, Australia)
Links
No website available
Profile paper DOI
Funders
Ministry of Foreign Affairs (Government, Netherlands)
National Cancer Institute (NCI) (Government, United States of America)
National Institute of Allergy and Infectious Diseases (NIAID) (Government, United States of America)
National Institutes of Health (NIH) (Government, United States of America)
The Foundation for AIDS Research (amFAR) (Third Sector, United States of America)
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- None
- None
- Healthcare data
Engagement
Keywords
